Mitchell Francis Kennedy

Mitchell Francis Kennedy


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2026 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
SASophia S. Antonioli
Sophia S. Antonioli
MKMitchell Francis Kennedy
Mitchell Francis Kennedy
CBCameron Bussey-Sutton
Cameron Bussey-Sutton
SMScott Marwin
Scott Marwin
RSRan Schwarzkopf
Ran Schwarzkopf
WMWilliam Macaulay
William Macaulay

13 December 2025 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
BSBenjamin C. Schaffler
Benjamin C. Schaffler
APAlana Prinos
Alana Prinos
MKMitchell Francis Kennedy
Mitchell Francis Kennedy
MEMallory Ehlers
Mallory Ehlers
JRJoshua C. Rozell
Joshua C. Rozell
RSRan Schwarzkopf
Ran Schwarzkopf

19 May 2026 in HIP International
Verified
Journal Article
Closed access
MKMitchell Francis Kennedy
Mitchell Francis Kennedy
CBCameron Bussey-Sutton
Cameron Bussey-Sutton
SASophia S. Antonioli
Sophia S. Antonioli
SMScott Marwin
Scott Marwin
RSRan Schwarzkopf
Ran Schwarzkopf
WMWilliam Macaulay
William Macaulay
Background: Hip resurfacing arthroplasty (HRA) is a femoral bone-preserving alternative to total hip arthroplasty (THA) for younger, active patients. However, complications such as fractures, loosening, and metal wear can require conversion to THA. In some cases, revision of both the acetabular and femoral components is required. Methods: We conducted a retrospective review of 15 patients who underwent conversion of HRA to THA at a single, academic tertiary care centre between January 2011 and April 2024. Demographic data, surgical details, implant characteristics, and indications for conversion were collected. Postoperative outcomes including complications, reoperations, and revisions were investigated. Revision-free survival was estimated using Kaplan-Meier analysis. Results: The mean age was 53.2 years and mean time to conversion was 6.7 years. Indications for conversion included adverse reaction to metal debris (ARMD; n = 6), mechanical loosening ( n = 3), component positioning and impingement ( n = 3), periprosthetic fracture ( n = 1), osteolysis/wear ( n = 1), and prosthetic joint infection (PJI; n = 1). Common reasons for acetabular cup revision included ARMD ( n = 6), loosening ( n = 4), and positioning ( n = 3). Dual-mobility (DM) constructs were used in 11 cases (73.3%). There were no dislocations. There was 1 90-day readmission due to persistent wound drainage which underwent debridement, antibiotics, and implant retention (DAIR) 14 days post-conversion. The average follow-up duration after the conversion procedure was 6.1 years. Kaplan-Meier analysis demonstrated 93% revision-free survival at one-year, which remained stable through 13 years. Conclusions: In this study of 15 both-component HRA conversions, we observed 93% revision-free survivorship at mid-term follow-up. While the small cohort size limits definitive conclusions, our findings suggest that revision of the acetabulum during conversion, particularly with dual-mobility constructs, may be an effective strategy to mitigate instability and manage metal-on-metal failure in appropriate patients. Further research with larger cohorts is warranted to confirm our findings.

19 May 2026 in HIP International
Verified
Journal Article
Closed access
SASophia S. Antonioli
Sophia S. Antonioli
APAlana Prinos
Alana Prinos
MKMitchell Francis Kennedy
Mitchell Francis Kennedy
AHAkram Habibi
Akram Habibi
DFDavid Furgiuele
David Furgiuele
RSRan Schwarzkopf
Ran Schwarzkopf
Introduction: Use of the direct anterior approach (DAA) in total hip arthroplasty (THA) has increased, with suggested benefits of faster recovery and less pain. However, consensus regarding the optimal approach is lacking. This study compared post-operative pain, functional recovery, and opioid use between DAA and posterior approach (PA) THA. Methods: We retrospectively reviewed 3618 primary THAs (DAA, n = 1809; PA, n = 1809) performed by fellowship-trained surgeons between 2019–2024. Cohorts were matched by age, sex, BMI, and CCI. Postoperative visual analogue scale (VAS) pain scores, Activity Measure for Post-Acute Care (AM-PAC) scores, and opioid consumption (morphine milligram equivalents, MME) were compared using independent t -tests. Results: Mean VAS pain scores were similar within the first 24 hours postoperatively. From 18 to 24 hours postoperatively, the PA cohort showed significantly higher VAS scores (4.32 [DAA] vs. 4.68 [PA], p = 0.006), although these differences are not clinically significant. Mean AM-PAC scores were significantly higher in the DAA cohort within 6 hours (22.3 [DAA] vs. 21.4 [PA], p < 0.001) and from 18 to 24 hours post-surgery (21.8 [DAA] vs. 20.1 [PA], p < 0.001), but these small differences do not reflect clinical significance. MME comparison showed a trend towards decreased opioid consumption within the DAA cohort, but the clinical relevance of these differences is unknown. Conclusions: Pain, function, and opioid use were largely comparable between DAA and PA, with minor statistical differences unlikely to be clinically meaningful.

1 October 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MKMitchell Francis Kennedy
Mitchell Francis Kennedy
BTBraden Terner
Braden Terner
CGChukwuweike Gwam
Chukwuweike Gwam
RSRan Schwarzkopf
Ran Schwarzkopf
Background: Total hip arthroplasty (THA) is a common procedure, yet instability and dislocation remain leading causes of revision. Dual mobility (DM) acetabular constructs improve stability, but comparative data across modular DM systems are limited. This study compared the safety and efficacy of three modular DM implants in primary THA, focusing on acetabular revision and functional recovery. Methods: We retrospectively reviewed 963 primary THAs performed from 2016–2024 using three modular DM systems. Patients with revision or bilateral THA, age < 18, or <2 years of follow-up were excluded. Outcomes included acetabular revision, 90-day readmission, and Hip Disability and Osteoarthritis Outcome Score for Joint Replacement (HOOS, JR). Kaplan–Meier analysis estimated 3-year implant survivorship for each implant, and non-inferiority of Implant A was tested against a combined “Dual Mobility Control” cohort (Implants B + C) using a prespecified −10% margin. Results: A total of 297 patients met inclusion criteria (142 Implant A, 110 Implant B, 45 Implant C). Revision rates were 4.9% for Implant A, 6.4% for Implant B, and 8.9% for Implant C. HOOS, JR scores improved significantly in all cohorts with comparable 2-year outcomes. Kaplan–Meier analysis showed 3-year survivorship of 98.3% for Implant A, 98.4% for Implant B, and 96.9% for Implant C (log-rank p = 0.053). The Dual Mobility Control cohort survivorship was 98.0%, and the difference between Implant A and controls (95% CI: −2.19% to 2.69%) met the non-inferiority margin (log-rank p = 0.796). Conclusions: Implant A demonstrated non-inferior 3-year survivorship and comparable short-term patient-reported outcomes relative to two other modular DM implants. Larger, multicenter studies with longer follow-up are warranted to confirm these findings.

20 February 2026 in Archives of orthopaedic and trauma surgery
Verified
Journal Article
Closed access
PDF file
JKJonathan Katzman
Jonathan Katzman
ZAZoe Alpert
Zoe Alpert
MKMitchell Francis Kennedy
Mitchell Francis Kennedy
JRJoshua C Rozell
Joshua C Rozell
RSRan Schwarzkopf
Ran Schwarzkopf
CLClaudette Lajam
Claudette Lajam